S100A9 and idiopathic pulmonary fibrosis: Third, we used only S100A9 and CD163 in circulating monocytes as pro-inflammatory and ant-inflammatory biomarkers, respectively, and found pro-inflammatory phenotypes in classical monocytes of IPF patients, and anti-inflammatory phenotypes in those of iNSIP patients.